With the exception of mature erythrocytes, cells within the human hematopoietic system are characterized by the cell surface expression of the pan-leukocyte receptor CD45. Here, we identify a novel subset among mononuclear cord blood cells depleted of lineage commitment markers (Lin -) 
INTRODUCTION
Human hematopoietic stem cells (HSCs) have been identified in bone marrow (BM), peripheral blood and umbilical cord blood (CB) [1] [2] [3] [4] . Initially, the functional capacity of the cells derived from these tissues was believed to be restricted to a hematopoietic cell fate. This view changed, however, when marrow-derived stromal cells were found to differentiate along the osteogenic lineage [5] [6] [7] . These new findings prompted further analysis of cells comprising the BM compartment, revealing that multipotent mesenchymal stem cells (MSCs) reside within the BM, and were capable of giving rise to adipose, bone, cartilage, skeletal muscle and endothelial cell lineages [8, 9] . These combined findings have led to the current notion that BM is therefore a source of both MSCs as well as HSCs. Similar to BM, human HSCs can also be found in umbilical CB and peripheral blood [2] [3] [4] , however, studies aimed at isolating mesenchymal cells from these alternative hematopoietic sources have provided mixed results. Cells from pre-term CB displayed mesenchymal properties [10] while more recent studies reported a lack of MSCs from full term CB [11, 12] . Similarly, contradicting reports have demonstrated the presence or absence of mesenchymal precursors from peripheral blood [12, 13] .
Human CB contains a combination of primitive cells and mature cells that have committed to the various hematopoietic lineages [14, 15] . Previous investigations have focused on the characterization and clinical utility of stem cells from CB partly due to the ease of obtaining this abundant cell source and the decreased immunogenicity of these cells upon allogenic transplantation [16, 17] . For hematopoietic cell fate, progenitors capable of multi-lineage hematopoiesis reside among cellular subsets of uncommitted CB cells that do not express specific hematopoietic lineage markers. These mature CB cells can be removed based on the surface expression of proteins associated with various hematopoietic lineages to derive a remaining subset of primitive cells referred to as the lineage depleted (Lin -) fraction [18] . Candidate human HSCs have been shown to exclusively reside in the Lin -fraction and can be further enriched to Lin -subsets expressing CD34 but devoid of CD38 (Lin -CD34 + CD38 -) [18] . Subsequent studies identified additional subpopulations of Lin -cells possessing hematopoietic progenitor function that was devoid of both CD34 and CD38 (Lin   -CD34   -CD38   - ), indicating that CD34 may not be unique to the human HSC phenotype [19] [20] [21] [22] [23] . This series of studies illustrates the heterogeneity of the Lin -CD34 -population in human CB and suggests that additional subpopulations may remain to be identified within the Lin -population. Here, we identify a novel population of cells in human CB devoid of the hematopoietic cell fate marker, CD45. Functional analysis of the Lin -
CD45
-CD34 -cells revealed that similar to CD45 -CD34 -cells from BM [8, 9] , these cells possess chondrocytic differentiation potential and hence share properties of mesenchymal progenitors. However, unlike BM-derived mesenchymal stem cells, CB derived Lin -CD45 -CD34 -cells possess unique de novo multi-lineage hematopoietic progenitor capacity. Lin 
CD34
-cells could not be propagated or maintained in conditions optimized for candidate HSC or MSCs. Using murine blastocysts to recapitulate an embryonic environment, Lin -CD45 -CD34 -cells displayed the ability to integrate into the ICM and underwent cell division. The functional potential displayed by this novel population suggests that Lin -CD45 -
-cells derived from human CB are potential therapeutic targets for cellular therapies for osteogenic as well as hematopoietic deficiencies and represent a population of human cells with unique developmental potential.
MATERIALS AND METHODS

Human and mouse mononuclear cell isolation and purification of primitive cell populations
Samples of full term human umbilical cord blood (CB) were obtained in conjunction with local ethical and biohazard authorities of the University of Western Ontario and London Health Sciences Centre. Mononuclear cells were collected by separation in Ficoll-paque (Pharmacia, Piscataway, NJ) as shown previously [18] . Lineage depleted (Lin -) cells were purified [18] and were stained with CD45 fluorescein isothiocyanate (FITC), CD34-allophycocyanate (APC) and CD38-peridinin chlorophyll protein-cyanin 5.5 (PCy5) monoclonal antibodies, and subsets isolated on a Vantage SE TM (Becton Dickinson). Bone marrow cells from EGFP transgenic mice (GFP/ FVB[TgN(ubEGFP)6752Dag]), generous gift from Dr. D Gray (University of Ottawa) were isolated by flushing the extracted tibia, femur, and iliac crest bones. Enrichment of undifferentiated primitive cells was carried out as previously described [24] and Sca-1 positive cells were isolated by cell sorting after staining with Sca-1-phycoerythrin (PE) (Becton Dickinson).
Membrane labeling of purified human and mouse subpopulations
Purified fractions were washed after cell sorting and 10,000-20, 000 cells in 200 µl volumes were labeled with 4 × 10 -6 M PKH-26 dye (Sigma-Aldrich) for 5 min at room temperature. Fetal bovine serum was added to stop the reaction and cells were washed 3 times with PBS.
Embryonic mouse limb bud cultures
Cultures were prepared from murine fore and hind limb buds of E11.25-E11.75 embryos (obtained from time-pregnant CD-1 femalesas previously described) [25] . Cells were digested with Dispase (GIBCO BRL) and filtered through a Cell Strainer (40 µm, Falcon) to obtain a single cell suspension. Mouse cells and human-mouse cocultures were cultured in tissue culture plastic (Nunc) or glass chamber slides (Falcon). Culture media (40% Dubelcco's Modified Eagle's Medium and 60% F12 supplemented with fetal bovine serum to 10%, GIBCO BRL) was changed daily. BMP-4 (R and D Systems) was added to culture media to concentration of 10 ng/ml. D 1 was considered to begin 24 h after initiation of culture. Labeled purified human subpopulations at 500 cells/10 µl were mixed with limb bud cells and plated. For each subpopulation, cells from 3 independent CB samples were divided into 12 wells for co-culture treatment. After 3 d, cells were washed and fixed with 4% paraformaldehyde followed by alcian blue staining for detection of cartilage nodules [26] and covered with plastic coverslips if needed. Visualization and collection of images was accomplished using a Zeiss epi-fluorescence microscope or an Olympus confocal laser scanning microscope for slides. Nuclear visualization was accomplished using DAPI Nuclear Counterstain Kit (Molecular Probes) or by covering slides with DAPI-containing mounting medium (Vector Laboratories).
In situ hybridization for detection of human chondrocytes
Whole-mount in situ hybridization of primary mesenchymal cultures was carried out as described before [25, 27] . Sense and antisense digoxigenin-incorporated riboprobes to human collagen type 9a2 (Col9a2) were prepared by in vitro transcription of a linearized EST clone (Accession number AI291668, obtained from MRC geneservice, Cambridge, UK) in which the 3' portion of the gene harboring the poly A sequence was deleted. This EST clone contains a region within the 3' UTR that is not shared with the mouse Col9a2 gene. Riboprobes to mouse Col9a2 were prepared in a similar manner using an EST clone (Accession number BC029697, obtained from the MRC geneservice, Cambridge, UK) in which ~1.5 kb of 3' sequence was deleted, generating a ~1.2 kb insert. All clones were verified by sequencing to confirm authenticity.
Analysis of chondrocyte-specific gene expression in limb bud cultures
De novo purified human cells, whole mouse cultures and mousehuman co-cultures were pelleted and used for mRNA isolation and cDNA synthesis (Amersham Biosciences). Amplification of transcripts was performed for 40 cycles using the following primer sets and annealing conditions. Aggrecan1: fwd. primer 5'-GGGTCAA-http://www.cell-research.com CAGTGCCTATCAG-3', rev. primer 5'-GGGTGTAGCGTGTA-GAGATG-3', at 57 o C for a 213 bp product (nested probe); Aggrecan 2: fwd. primer 5'-CCAAGAATCAAGTGGAGCCGTG-3', rev. primer 5'-GATGGGGTATCTGACAGTCTGGTC-3', at 65.2 o C for a 429 bp product. Amplified products were isolated and sequenced to verify the specificity of the gene amplification.
Colony forming assays
Human clonogenic progenitor assays were performed by plating 200-3000 purified cells into serum-free Methocult H4236 (Stem Cell Technologies) containing 300 ng/ml rhu-Stem cell factor and Flt-3 ligand, 10 ng/ml rhu-Interleukin-6 and rhu-Interleukin-3, 50 ng/ml Granulocyte-Colony Stimulating Factor and 3 units/ml rhuErythropoietin. Differential colony counts were assessed by morphology following incubations for 10-14 d at 37 o C and 5% CO 2 in a humidified atmosphere.
In vitro culture of purified human subpopulations
Purified cells were placed in 96-well fibronectin-coated plates at 200-1500 cells per well. Media included mesencult media (Stem Cell Technologies), IMDM (GIBCO BRL) based media with BIT supplement (BSA, insulin, transferrin), M199 media (GIBCO BRL) with the following growth factors if desired; 10 ng/ml FGF or EGF, hematopoietic growth factors include 300 ng/ml SCF and Flt-3, 10 ng/ml interleukin-3 and interleukin-6 and 50 ng/ml granulocyte-colony stimulating factor, 25% human umbilical vein endothelial cell supernatant and 5% chick embryo extract. The day after seeding (d 1), the cells were counted in situ by bright-field microscopy to establish initial cell numbers and tracked for up to 32 d. 
Mouse embryo collection
Injection or aggregation with murine blastocysts
All injections and aggregations were performed using a micromanipulator (Narishige) and Hoffman Modulation contrast microscopy. Drops (50- 
RESULTS
Identification and characterization of Lin -CD45 -cells in human cord blood
The pan-leukocyte marker, CD45, is a receptor tyrosine phosphatase that is expressed on the majority of cells in the hematopoietic system and is absent in other tissues [28] . Hence, CD45 has been used as an indication of hematopoietic commitment [29] . To obtain the primitive Lin -population, CB cells are depleted of mature cells by negative selection which removes cells expressing protein surface markers of mature hematopoietic cells similar to that previously demonstrated [19] . Human CB Lin -cells were analyzed using FACS for expression of the hematopoietic marker, CD45. Viable cells were selected based on forward and side scatter properties (Fig. 1A ) (gated R1) and the exclusion of the viability dye propidium iodide (Fig. 1B) (gated R2). When analyzed for the expression of CD45, the lineage depleted CB cells showed a heterogeneous expression of the pan-leukocyte marker with 3 distinct subpopulations. The majority of the cells (56.9% ± 4.6, n=11) expressed CD45 at either a high MFI (Mean Fluorescence Intensity) of 662.25 or (41.1% ± 4.9, n=1) moderate MFI of 132.10 ( Fig. 1C) . A small proportion of Lin -cells were devoid of CD45 expression (Fig. 1C) and represented an average of 1.92% ± 0.36 (n=11) of the total Lin -CB cells. Further analysis of these cells for expression of the primitive hematopoietic marker, CD34, revealed that the majority of CD45 -cells were also absent for CD34 (71.8% ± 6.8, n=9). The absence of CD45 was in direct contrast to the expression of previously characterized Lin -CD34 + CD38
cells, which were nearly completely positive for moderate levels of CD45 (99.0% ± 0.6, n=11) ( Fig. 1D [30, 31] are also capable of primitive hematopoietic function [21] , however, the CD45 expression of these rarer Lin -
CD34
-HSCs has not been evaluated. Our analysis revealed that Lin -CD45 -CD34 -cells do not co-express AC133 (Fig. 1E ). In addition, further characterization of Lin 
+ CD38 -cells ( Fig 1F) . All populations were found to lack the hematopoietic maturation marker, CD38, despite the presence or absence of CD34 or CD45 (Fig. 1G) . We suggest that CB Lin -CD45 -CD34 -cells represent a novel population that is phenotypically distinct from all other previously characterized subsets derived from human CB [21] .
Human Lin -CD45 -CD34 -cells contribute to early cartilage condensations characteristic of chondrocyte precursors
To determine if Lin -CD45 -CD34 -cells were capable of differentiation into a mesenchymal lineage, isolated subsets of human CB cells were co-cultured with primary embryonic murine limb bud cells and analyzed for chondrocytic cell fate potential. The murine cultures initially consist of a heterogeneous collection of mesenchymal cells, some of which become cartilage precursors or chondrocytes committed to cartilage formation as previously shown [32] . Such chondrocytes actively aggregate and exclude other cell types, resulting in condensations that appear to be nodules of high cell density among scattered individual mesenchymal cells [33] . Cells within the mesodermal condensations then differentiate into chondrocytes and begin production of cartilage specific glycosaminoglycans that can be identified by alcian blue staining [26, 34] . Based on this murine assay for chondrogenic development, we surmised that co-culture of human cells with murine limb bud cells would allow for identification of human progenitors with chondrocytic potential. 
CD38
-cells known to be enriched for hematopoietic progenitors and HSCs. To assure that PKH26 dye transfer to mouse limb bud cells did not occur in this assay system, we labeled the membranes of putative mouse HSCs expressing Stem Cell Antigen-1 (Sca-1) [24] , from the bone marrow of mice carrying the EGFP transgene [37] . These cells were stained with PKH26 and co-cultured with non-transgenic limb bud cells for 3 d after which, the cultures were analyzed for the co-expression of GFP and PKH26 using confocal microscopy. Results demonstrated that of the 50 PKH-labeled cells examined, all cells retaining the membrane dye ( Fig. 2A b) were also co-expressing GFP ( Fig. 2A a) . The overlay of both fluorescent markers indicates that cells positive for the membrane dye PKH26 (red) were also GFP+ ( Fig. 2 A c) and similarly, all GFP+ cells demonstrated PKH fluo-rescence. It is important to note that PKH+ cells were only detected in the periphery and not in the nodules suggesting that despite their mouse origin, the highly purified cells possessing potent hematopoietic capacity may be unable to differentiate along the cartilage lineage. Unstained GFP+ cells were also used to establish levels of non-specific red fluorescence as an experimental control ( Fig. 2A d-f) . Thus, dye transfer does not occur in co-cultures of membrane labeled PKH26+ cells in this assay.
Given these controls for the integrity of the cell labeling and lack of dye transfer, which could lead to false positives in co-cultured conditions, subsets of human cells were co-cultured with limb bud cells and subsequently fixed and stained with alcian blue to reveal cartilage nodules (Fig. 2B a-c) . Epi-fluorescence microscopy was used to follow the distribution of human cells within the cultures and to specifically detect the presence of human cells within cartilage nodules. Unlabeled cells were also used to establish background levels of fluorescence (Fig. 2B d) . Labeled Lin -CD45 -CD34 -cells could be detected within the cartilage nodules of the cultures (Fig. 2B e-h ) exhibiting morphological features of differentiating chondrocytes such as an ovular cell shape (Fig. 2B g, h) and the absence of long processes characteristic of mesenchymal cell types (Fig. 2B l) . Detection of human cells in the nodules was not, however, restricted to the Lin -CD34 -CD45 -cells.
Though the majority of labeled Lin -CD34 + CD38 -cells were excluded from the nodules, a very small proportion (0.15%) could be detected within the nodules (Fig. 3C) . Human cells lacking chondrocytic potential could also be detected among the layer of surrounding mesenchymal cells (Fig.  2B i) , exhibiting the round, spherical shape characteristic of hematopoietic cells after co-culture with Lin -CD45 -CD34 -cells (Fig. 2B j, k) and Lin -CD34 + CD38 - (Fig. 2B  m, n) . This analysis suggests that Lin -CD45 -CD34 -cells possessed functional properties associated with chondrocytic potential by integration into murine nodules (Fig. 2B) .
Detection of PKH-labeled human chondrocytes is unlikely to be due to cell fusion as previously documented cell fusion events could only be induced in long-term cultures in the presence of selective pressure [38] [39] [40] [41] . The limb bud co-cultures were not subjected to such selective conditions and were maintained for a short period of three days, a time point at which cell fusion was previously not detected. Furthermore, limb bud cultures stained with DAPI revealed a single nuclear component (Fig. 2C a, 
-cells and demonstrated the greatest potential in the presence of the TGF-β superfamily ligand, BMP-4 (Fig. 3A) .The addition of BMP-4 significantly increased the number of detectable human Lin   -CD45   -CD34 -cells within the nodules (p<0.005) compared to Lin -CD34 + CD38 -cells, suggesting this mesodermal factor may also be important to the differentiation of this novel population into cartilage precursors (Fig. 3A) 
-cells (p<0.005). To confirm development of human chondrocytic cells, co-cultures were assessed for the expression of cartilagespecific chondrocyte markers. Human CB populations were initially analyzed using RT-PCR for the cartilage specific transcript, Aggrecan (Agc), which is an abundant cartilage matrix protein expressed exclusively in later stages of chondrocyte differentiation [42] . De novo Lin   -CD45   -CD34   -and Lin   -CD34 + CD38 -cells displayed undetectable levels of Agc transcript as assessed by RT-PCR using human specific primers or following southern transfer and hybridization with a radiolabeled nested fragment of human Agc (Fig. 3B a, lanes 5, 6) . No product was detected in mouse limb bud cultures alone, indicating the specificity of the analysis to human Agc transcripts only (Fig. 3B a,  lanes 3, 4) . After co-culture with mouse limb bud cells, transcript for human Agc could be detected in Lin -CD45 -CD34 -co-cultures (Fig. 3B a, lane 8) . Human-mouse cocultures were also performed in the presence of BMP-4, which has been shown to stimulate cartilage production by increasing the number of chondrocyte nodules [25, 43] . It is of interest to note that Agc expression could only be detected in the presence of BMP-4 illustrating the importance of this morphogen in mediating cartilage development from Lin -CD45 -CD34 -cells (Fig. 3B a, lane 8) . Aggrecan transcript could not be detected in amplifications using mRNA from greater numbers of human cells to which reverse transcriptase was not added (Fig. 3B b) . Thus, the product seen in the cultures containing human cells is most likely not due to DNA contamination. Similarly, detection of Agc in co-cultures with Lin -CD34 +
-cells was only demonstrated in co-cultures in the presence of BMP-4 (data not shown), which is expected, as a small number of chondrocytes were detected in the co-cultures seeded with Lin -CD34 + CD38 -cells (Fig. 3A) . 
CD45
-CD34 -cells in cartilage nodules (f, g, white arrows) that are surrounded by the alcian blue-stained matrix (e, black arrow). Co-cultured Lin -
-CD34 -cells located within the stained nodules exhibited chondrocyte-like morphology (f, g). Co-cultures were also seeded in chamber slides, fixed and mounted to confirm that labeled human Lin -CD45 -CD34 -cells within the cartilage nodules did adopt chondrocyte-like morphology using confocal microscopy (h). Lin -CD45 -CD34 -cells could also be identified exhibiting round, hematopoietic cell morphology (j, k), and were excluded from nodules indicated by the lack of alcian blue staining (i). Labeled cells with mesenchymal cell morphology in non-cartilage regions could also be identified after co-culture (l) as well as Lin -CD34 + CD38 -cells located outside cartilage nodules that maintained a round hematopoietic-like cell morphology (m, n). All images were captured from control or co-cultures containing 10 ng/ml BMP-4. ing a human-specific Col9a2 probe. Type 2, 9 and 11 collagens are abundantly expressed in cartilage [42, 44, 45] . Scrutiny of these genes for regions specific to the human coding sequence revealed that the Col9a2 gene contained a large region (~600 bp) within the 3' UTR that was not shared with its mouse counterpart, nor within the current version of the murine genome. For control purposes, cultures were hybridized with a mouse specific Col9a2 probe to identify regions in the cultures that contain Col9a2-expressing mouse cells. Similar to previous experiments, Lin -
-CD34 -cells were co-cultured only then assessed for human Col9a2 expression rather than membrane fluorescence. Instability of the PKH membrane dye caused by the reagents in the in situ protocol prevented simultaneous use of these two techniques, however, in situ analysis has previously been accepted as a reliable method for the detection of cartilage transcripts in the limb bud cultures [25] . Analysis of the murine cultures demonstrated that a subset of the cells, located in the central region of the nodules, expressed Col9a2 (Fig. 3C a) . In contrast, this pattern of expression was not observed in the sense control probe (Fig. 3C b) . The region of detection is consistent with the predicted expression pattern of Col9a2, which is typically expressed in slightly more mature chondrocytes [45] that would be distributed within the core of the nodules where the more differentiated cells reside. Some staining was observed in cells circumscribing the nodules, however, this also appeared in the sense controls demonstrating non-specific binding of the probe for Col9a2. In mixed human-mouse cultures containing human Lin -CD45 -
CD34
-cells in the presence of BMP-4, human Col9a2 expression can be seen in small foci of cells within the nodules (Fig. 3C c, black arrow) . Similar to the expression of Agc, human Col9a2 transcript could be detected in co-cultures containing Lin -CD45 -CD34 -compared to mouse only cultures and required the presence of BMP-4. Using this human specific in situ probe, no staining was observed in regions around the nodules in the absence of human co-cultured cells. Control cultures using a human specific sense probe in mixed cultures (Fig. 3C d) or antisense probe in mouse-only cultures (Fig. 3C e) -cells were plated in colonyforming unit (CFU) assays to determine if these cells were capable of hematopoietic colony formation [46] . Surprisingly, 
CD38
-cells where RT was not added produced no product (b, lane 3) confirming the lack of DNA contamination. (C) Chondrocyte differentiation was further confirmed by in situ hybridization using an antisense probe specific to mouseCol9a2 (a) and corresponding sense-strand mouse probe (b) to ensure mRNA specificity. Using a human-specific antisense probe, expression of Col9a2 could be detected within the nodules of co-cultures containing Lin -CD45 -CD34 -cells and BMP-4 (c, black arrow), while the sense-strand probe was unable to hybridize (d). The human Col9A2 anti-sense probe showed a lack of staining in mouse only cultures eliminating the possibility of cross-species contamination (e).
a b cells phenotypically uncommitted to the hematopoietic lineage indicated by the lack of CD45 expression were capable of proliferation and differentiation characteristic of primitive hematopoietic progenitors (Fig. 4A) . Quantitative analysis determined that 1 in 100 Lin 
CD34
+ CD38 -, which does express CD45, showed that this population was highly enriched for hematopoietic progenitors exhibiting a clonogenic efficiency of 1 in 3.8 (Fig. 4A) , similar to previous reports [19, 47] . Though (Fig. 4B) . Each population showed similar composition of the various hematopoietic colonies with the exception of the number of tetrapotent colonies. This type of colony develops from the proliferation and differentiation of a clonogenic progenitor (CFU) that is able to produce cells of four distinct hematopoietic lineages that include granulocytes, erythroid cells, macrophages, and mega-karocytes (GEMM) [48, 49] . As much as 13. 
-cells was hindered by the inability to iden- 
-(grey) and Lin -CD34 + CD38 -cells (white) was calculated as the average percent of the total number of colonies ± SEM for each colony type to identify differences in progenitor development. Colonies detected consisted of Burst-forming unit-Erythroid (BFU-E) and Colony Forming Units-Macrophage (CFU-M), -Granulocyte (CFU-G), Granulocyte-Macrophage (CFU-GM), and the tetrapotent unit able to form all colony types from a single progenitor (CFU-GEMM).
tify an in vitro environment that could support this population. Cells were cultured in serum-free medium and serum-containing media with added hematopoietic growth factors, fibroblast growth factor (bFGF), chick embryo extract, human umbilical vein endothelial cell conditioned media (HUVEC), and media optimized for mesenchymal cells [50, 51] . In all conditions, cell counts declined rapidly over time and sufficient numbers for subsequent analysis were unobtainable (data not shown). In contrast, after 8 d, Lin   -CD34   +   CD38 -cells proliferated 10-fold or greater in all conditions used with the exception of the mesenchymal cell medium (data not shown). Despite failure to maintain these cells in various culture conditions, presence of Lin -
CD45
-CD34 -cells or derivatives generated by co-culture with embryonic limb buds suggests that a primary embryonic environment may be required for the survival of these human CB cells.
To further examine the survival of human CB subsets, purified cells were injected or aggregated with blastocysts from immune-competent CD1 mice to determine if these human cells could persist within the embryonic environment by integrating with the ICM. Initial experiments were performed where integration of labeled human cells with murine blastocyst cells was accomplished by cellular aggregation. Lin  -CD45  -CD34  -and Lin   -CD34  + CD38 -cells were stained with PKH26 membrane dye and 1-4 human cells were aggregated with a single murine blastocyst after removal of the zona pellucida. For comparison, a mature myeloid population expressing CD33 was also stained and assayed in the same manner. Cells were allowed to aggre- gate for 2 d after which the number of blastocysts containing a fluorescent human cell was tracked over the next 5 d. Media from stained cells was also used for injection to assure that dye leakage would not affect the definitive detection of the human cells (Fig. 5D a) . The number of blastocysts with human cells steadily declined following aggregation with all populations. After 48 h, CD33 + mature myeloid cells displayed a rapid decrease with only 10% of the aggregated blastocysts having detectable integrated human cells (Fig. 5A, grey bars) . In contrast, both primitive populations displayed a higher rate of survival than the mature CD33 + population throughout the culture period. Lin -CD45 -CD34 -cells exhibited the greatest microchimerization potential as more than 70% of the initial blastocysts still contained at least one human cell by the end of the tracking period after aggregation (Fig. 5A , black bars). Lin -CD34 + CD38 -cells declined further with 56% of the chimerized blastocysts persisting by d 6 (Fig. 5A, white bars) . This data suggests that the Lin -
-CD34 -cells may possess a survival advantage in the mouse embryo, although in some cases aggregations were performed with multiple human cells. Furthermore 
CD34
+ CD38 -cells within a blastocyst dropped to less than 5 (9.3 %) after 5 d, despite an initial total number of 43 successfully injected blastocysts at d 0 (Fig. 5B, white bars) . By the last day of tracking (d 6), no Lin -CD34 + CD38 -cells were detected within the murine blastocysts (Fig. 5D c) . Lin -CD45 -CD34 -cells declined more slowly with approximately 55% of injected blastocysts still containing at least one detectable human cell after 3 d (Fig. 5D b) . This proportion dropped minimally over the rest of the culture period, reaching 41% of the total by d 6 (Fig. 5B, black bars) -cells was greater when chimerization was achieved through aggregation suggesting that these cells may require co-operativity or interaction to survive.
Using two independent methods for microchimerization, we have shown that the responsiveness of cells to an environment provided by an intact embryo is greatest in the Lin -CD45 -CD34 -population similar to the results seen in the chondrocyte assays. Thus, these primary cell environments may be providing the crucial signals required by a very primitive population, which cannot be recapitulated by current in vitro techniques. Furthermore, the murine blastocyst environment also appears to promote the proliferation of the chimerized human cells. Results showed that the number of detectable human Lin   -CD45   -CD34 -cells within a single blastocyst after single-cell injection increased over time with a 6-fold increase in cell number by d 5 and d 6 (Fig. 5C) 
-population is able to persist and microchimerize the murine blastocysts, has a greater survival rate as well as superior potential for proliferation than other primitive and mature subsets.
DISCUSSION
Our report demonstrates the identification of a novel human cell population which is distinct from previously characterized CB populations and capable of hematopoietic and chondrocytic differentiation. [53] [54] [55] .
Despite the identification of this novel population of human CB derived cells, our current findings do not conclusively determine if the resulting differentiated hematopoietic cells and chondrocytes arise from a single common precursor cell or whether the Lin   -CD45   -CD34 -population is comprised of co-existing hematopoietic and chondrogenic precursors. In the absence of identifying retroviral integration sites common to both hematopoietic and chondrocytic progeny differentiated from Lin -CD45 -
CD34
-cells or single clonal culture assays, we are unable to support either theory. As demonstrated here, culture conditions required to maintain these novel cells for a limited period are not available, and therefore neither of these strategies is feasible based on our current knowledge of this novel population. However, since the mouse blastocyst environment provides some beneficial effects on the survival of Lin 
cells (data not shown). This factor has been implicated in the development of mesodermal cell fates [56] [57] [58] [59] . Treatment with BMP-4 has also been shown to increase the number of progenitors in the Lin -CD34
+ CD38 -population and prolong the survival of these candidate HSCs [60] . In addition, the BMP pathway has been shown to be important to murine chondrogenesis [61, 62] as well as human fracture repair [63] . Both Lin 
CD38
-cells express both type I BMP receptors, ALK-3 and ALK-6 (data not shown), however, we are unable to conclude if the cells expressing the BMP receptors are the same cells that are located within the nodules. At this point, the mechanism by which BMP increases the detection of human cells within the nodules is unknown. The BMP protein may directly affect the human cells or simply target the murine cells to allow a more favorable environment to the labeled human cells. Therefore, though the mechanism is unknown, our results demonstrate that similar to the effect documented in the mouse system [25] , BMP-4 also causes an increase in cartilage development and differentiation of human chondrogenic precursors.
Multipotent capacity of mammalian cells and embryonic environments
Lin -CD45 -CD34 -cells share characteristics with recently reported mesodermal progenitor cells (MPCs) isolated from BM that are also devoid of CD34 and CD45 expression [9, 64] . The differentiation potential of MPCs is dependent on the culture conditions demonstrating the importance of the inductive signals required for tissue differentiation. MPCs were unable to produce hematopoietic cells yet can be used as a support system for purified hematopoietic cells [65] . Cells resident in the BM with non-hematopoietic potential may indicate the existence of a common ancestor that possesses properties of both primitive hematopoietic and mesenchymal cells. However, initial studies were unable to demonstrate a mesenchymal stem cell with hematopoietic potential [8, 9] . Mouse bone marrow cells, termed multipotent adult progenitor cells (MAPCs), have now been identified which demonstrate pluripotency after integration with murine blastocysts and transfer into foster mothers to produce chimeric offspring [66] . In addition, the embryonic environment may be crucial to the inductive process of tissue specification as injected neural stem cells are able to chimerize the embryo and contribute to the formation of other tissues such as heart and liver [67] . Hence, this early embryonic environment appears to provide the proper environment for demonstrating multipotentiality of this adult derived mammalian cell population.
Human Lin -CD45 -CD34 -cells identified here are distinct from previously identified adult BM-derived CD45 -cells [8, 9, 66] in that they display de novo hematopoietic function. In addition, in contrast to MAPCs, Lin -CD45 -CD34 -cells derived from CB can be prospectively isolated, and do not require serial passages in vitro for derivation. The importance of embryonic environments appears to be crucial to the differentiation and survival of Lin -CD45 -CD34 -cells as attempts to maintain these cells in culture using a variety of media were unable to support these cells. The Lin -CD45 -CD34 -cells displayed greater differentiation potential in the presence of primary embryonic tissue, such as limb bud cultures, and greater survival and proliferative capacity upon integration with murine blastocysts compared to Lin -CD34 + CD38 -cells. This assay may serve as an efficient new model for examining cells with primitive cell proliferation and differentiation potential that is able to mimic unique embryonic environments required for candidate stem cells that may possess multipotent differentiation capacity, thereby providing an alternative to measure cell fate ability of newly identified human stem cells. By providing extrinsic factors not available to adult specified stem cells, murine blastocysts chimerized with human cells may provide insights into early developmental events of human cells using in situ techniques for the detection of genes critical to stem cell regulation. In addition, chimerized blastocysts may be used for transfer into foster mothers so that the human cells may be studied in an in vivo environment. The early embryonic environment can also be assessed for a role in cellular re-programming by determining if exposure to the blastocyst cells changes the gene expression profile of the injected cells. The use of fluorescent dyes shown in our current study allows the human cells to be tracked as well as a marker for isolation using flow cytometric isolation. Adaptation of this system in experiments aimed to characterize primitive populations may reveal undiscovered cellular potentials of adult human cells that were previously undetectable due to limitations of currently used models such as xeno-transplantation into adult recipients. In addition, by using blastocysts from mutant mice with gene deletions or overexpressing specific transgenes, this assay creates a powerful tool for examining extrinsic regulatory factors hypothesized to be important for adult human stem cell regulation and in vivo cell fate induction. Our current study illustrates the importance of using this assay for the characterization of novel stem cell populations derived from human sources. The cellular potential of the Lin -CD45
-CD34 -cells identified here could only be detected in the presence of an embryonic environment and hence this assay will be a focus for further characterization of this and other novel human stem cell populations in our laboratory.
